Carmine N. Stengone

CTNM

Carmine N. Stengone serves as director, officer: CEO and President at Contineum Therapeutics, Inc. (CTNM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$4.6K

Total Sells

6 trades

$401.4K

Net Position

Net Seller

$396.8K

Companies Traded

CTNM, KPRX

Active Period

Sep 2024 – Sep 2026

7 total trades

Most Recent

Sell CTNM

Sep 8, 2026 · $41.1K

Carmine N. Stengone's Insider Trading at Contineum Therapeutics, Inc. (CTNM)

Buys

0 · $0.00

Sells

6 · $401.4K

Total Shares Bought

Total Shares Sold

25,000

CTNM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 8, 2026	Sell	2,500	$16.46	$41.1K	17,217
Aug 3, 2026	Sell	2,500	$16.01	$40.0K	17,217
Jul 8, 2026	Sell	2,500	$16.00	$40.0K	17,217
Jul 1, 2026	Sell	10,000	$16.01	$160.1K	17,217
Feb 26, 2026	Sell	7,100	$16.02	$113.7K	14,954
Feb 11, 2026	Sell	400	$16.00	$6.4K	0

Carmine N. Stengone's Insider Trading at Kiora Pharmaceuticals, Inc. (KPRX)

Buys

1 · $4.6K

Sells

0 · $0.00

Total Shares Bought

1,250

Total Shares Sold

KPRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 12, 2024	Buy	1,250	$3.68	$4.6K	1,250

Related Insiders

Daniel S. Lorrain

officer: Chief Scientific Officer

CTNMSell · Jul 10, 2026

Tim Watkins

officer: CMO & Head of Development

CTNMSell · Jul 1, 2026

Explore More Insider Trading Data

CTNM Insider Trading Activity

View all insider trades at Contineum Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity